The most prudent course today would be to conduct careful clinical trials with due scientific deliberation; use the vaccine on high-risk groups, phasing in the full population only as evidence of safety and effectiveness becomes clearer; and conducting post-market surveillance for adverse effects. (Lawrence Gostin in The Oz Global goal for vaccine quest)
See also WHO: Pandemic Influenza Vaccine Manufacturing Process and Timeline
Tgk1946's Blog 